Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Mar 15, 2022; 14(3): 646-653
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.646
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.646
Table 1 Sensitivity and specificity of magnifying chromoendoscopy to diagnose neoplasia in inflammatory bowel disease
Lesions assessed with MC (n) | Pit patterns | Sensitivity | Specificity | |
Kiesslich et al[9], 2003 | 87 | III-V | 93% | 93% |
Carballal et al[10], 2018 | 444 | III-V | 70% | 90% |
Shinagawa et al[12], 2019 | 769 | III-V | 77.4% | 89.5% |
Aladrén et al[13], 2019 | 709 | III-V | 36% | 94% |
Bisschops et al[14], 2017 | 50 | III-V | 77% | 68% |
Hata et al[15], 2004 | 35 | III-V | 100% | 57% |
Kudo et al[26], 2021 | 103 | III-V | 97.8% | 57.5% |
Kudo et al[26], 2021 | 103 | V or II-IV with EC irregular-formed nuclei | 100% | 84.4% |
- Citation: Akiyama S, Sakamoto T, Steinberg JM, Saito Y, Tsuchiya K. Evolving roles of magnifying endoscopy and endoscopic resection for neoplasia in inflammatory bowel diseases. World J Gastrointest Oncol 2022; 14(3): 646-653
- URL: https://www.wjgnet.com/1948-5204/full/v14/i3/646.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i3.646